Private outpatient mental healthcare company Onebright has significantly expanded its neurodevelopmental services with the acquisition of Psicon Ltd for an undisclosed sum.
Onebright provides a wide range of market-leading mental healthcare services, including neurodevelopmental assessments, to its private medical insurance, corporate, and consumer clients. With the addition of Psicon, the mental healthcare company has increased its breadth and depth of capabilities in this important area.
Growing interest in neurodiversity
Psicon is a rapidly growing provider of neurodevelopmental assessments for Autism and ADHD, and works extensively with the NHS, as well as providing private assessments to the public. The organisation offers a full range of assessment and treatment services across the lifespan and is one of the largest providers of children’s neurodevelopmental services in the UK.
The two brands will operate independently with Psicon continuing to be led by Managing Director Dr Dan Simmonds. With the support of Onebright it will significantly invest in its operational and technology capabilities and continue its UK expansion to enable more people to benefit from its services.
The new enlarged group will employ over 500 staff delivering services remotely and from a growing number of face-to-face clinics. Its operational centres are in York, London, and Canterbury.
Commenting on the acquisition Donald Fowler, CEO of Onebright, said:
“We are delighted to welcome Psicon to the Onebright family. Our mission at Onebright is to create a brighter tomorrow by providing easy access to personalised, life-changing mental health support, and the addition of Psicon and its team to our group will really enhance our ability to deliver on this mission. From very early on in our discussions it was apparent that our two organisations share a passion for clinical excellence and patient-centred care, and I am really looking forward to what we can achieve together.”
Commenting Dr Dan Simmonds, Managing Director of Psicon, said:
“Demand for high-quality support for the neurodivergent population has increased substantially up and down the country and we look forward to working within the Onebright family to further support NHS Trusts, Integrated Care Boards, and private patients across the UK.”
Onebright mission is to create a brighter tomorrow by providing easy access to personalised, life-changing mental health support, and our vision is to be a leading international specialist provider of mental health services for clinicians and individuals.
Changing lives for the better
Onebright supports more than 55,000 individuals per year with outpatient mental healthcare, and over 200 businesses as clients. They also work with employee assistance programmes, private medical insurance providers, and occupational health to help individuals.
Their services include cognitive behavioural therapy (CBT), psychiatry, and counselling, and they assess, diagnose, and treat a range of conditions, such as anxiety and depression, stress, PTSD, trauma, OCD, eating disorders, and many more – from the first interaction through to recovery.
Onebright are Gold Sponsors of the MAD World Summit. Their CCO, Shamira Graham wil be taking to the stage on 12th October, alongside Dr Shaun Davis from Belron International, Oliver Henry from EasyJet and Professor Marcantonio Spada from London South Bank University , to about preparing and implementing your wellbeing strategy. They’ll be joined by an an impressive roster of speakers from Age UK, BAM UK&I, BBC, Belron, BITC, Britvic, Costain, Deloitte, Dentsu, EY, Goldman Sachs, Heath Foundation, Heathrow, HSBC, IBM, Ipsos, Mars, Metro Bank, Microsoft, Mind, National Grid, Novartis, Unipart, Royal Bank of Scotland, Starbucks and many more.
If you haven’t booked your tickets yet, don’t miss out. You can find full details and book here.
You might also like:
